Quest Diagnostics, West Norriton, PA, USA.
Am J Obstet Gynecol. 2012 Jul;207(1):55.e1-8. doi: 10.1016/j.ajog.2012.04.027. Epub 2012 Apr 30.
The objective of the study was to estimate the rates of testing, prevalence, and follow-up testing for chlamydial and gonococcal infection in a nationally based population that is comparable with the US pregnant population in terms of age and race.
We extracted laboratory results for 1,293,423 pregnant women tested over a 3-year period.
During pregnancy, 59% (761,315 of 1,293,423) and 57% (730,796 of 1,293,423) of women were tested at least once for Chlamydia trachomatis or for Neisseria gonorrhoeae, respectively. Of those women tested, 3.5% (26,437 of 761,315) and 0.6% (4605 of 730,796) tested positive for chlamydial and gonococcal infection, respectively, at least once during pregnancy. Of those women who were initially positive for the given infection, 78% (16,039 of 20,489) and 76% (2610 of 3435) were retested, of whom 6.0% (969 of 16,039) and 3.8% (100 of 2610) were positive on their last prenatal test for C trachomatis and N gonorrhoeae, respectively.
Many pregnant women are not tested for C trachomatis and N gonorrhoeae despite recommendations to test. Follow-up testing to monitor the effectiveness of treatment is also not always performed.
本研究旨在评估在一个全国性的人群中，衣原体和淋病感染的检测率、流行率和随访检测率，该人群在年龄和种族方面与美国孕妇人群具有可比性。
我们提取了在 3 年期间接受检测的 1,293,423 名孕妇的实验室检测结果。
在怀孕期间，59%（761,315 名/1,293,423 名）和 57%（730,796 名/1,293,423 名）的女性至少接受过一次衣原体或淋病奈瑟菌的检测。在接受检测的女性中，3.5%（26,437 名/761,315 名）和 0.6%（4605 名/730,796 名）至少有一次在怀孕期间检测出衣原体和淋病奈瑟菌感染呈阳性。在最初感染该疾病的女性中，78%（16,039 名/20,489 名）和 76%（2610 名/3435 名）进行了复查，其中 6.0%（969 名/16,039 名）和 3.8%（100 名/2610 名）在最后一次产前衣原体和淋病奈瑟菌检测中呈阳性。
尽管有检测建议，但许多孕妇并未接受衣原体和淋病奈瑟菌的检测。也并非总是进行随访检测以监测治疗效果。
